Literature DB >> 24982395

Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan.

Chia-Wen Tsai1, Wen-Shin Chang2, Kuo-Cheng Lin3, Liang-Chun Shih4, Ming-Hsui Tsai5, Chieh-Lun Hsiao2, Mei-Due Yang2, Cheng-Chieh Lin6, Da-Tian Bau7.   

Abstract

Interleukin-10 (IL10) is an immunosuppressive cytokine which may facilitate carcinogenesis by down-regulating interferon-gamma production and supporting tumor escape from the immune response. Polymorphisms within the promoter of IL10 gene may not only contribute to differential IL10 expression levels among individuals but also to oral cancer susceptibility. In this hospital-based study, the association of IL10 A-1082G (rs1800896), T-819C (rs3021097), and A-592C (rs1800872) polymorphisms with oral cancer risk were examined. A total of 788 cases with oral cancer risk and 956 controls were genotypes and analyzed by polymerase chain reaction and restriction fragment length polymorphism. The results showed that there were significant differential distributions among oral cancer cases and controls in the genotypic (p=6.29×10(-11)) and allelic (p=2.80×10(-13)) frequencies of IL10 A-1082G. Individuals who carried the AG or GG genotype for IL10 A-1082G had a 1.90- and 3.27-fold higher risk, respectively, of developing nasopharyngeal carcinoma compared to those who carried AA genotype (95% confidence interval=1.51-2.39 and 1.95-5.47). None of the other two polymorphisms investigated appear to affect cancer risk. In gene-lifestyle interaction analysis, we provide first evidence showing of an obvious joint effect of IL10 A-1082G genotype with individual smoking and areca chewing habits on nasopharyngeal carcinoma risk. The AG and GG genotypes of IL10 A-1082G, together with smoking and areca chewing habits, synergistically contribute to individual susceptibility for oral cancer. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Carcinogenesis; IL10; oral cancer; polymorphism

Mesh:

Substances:

Year:  2014        PMID: 24982395

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  DNA double-strand break repair gene XRCC7 genotypes were associated with hepatocellular carcinoma risk in Taiwanese males and alcohol drinkers.

Authors:  Yi-Hsien Hsieh; Wen-Shin Chang; Chia-Wen Tsai; Jen-Pi Tsai; Chin-Mu Hsu; Long-Bin Jeng; Da-Tian Bau
Journal:  Tumour Biol       Date:  2015-05-06

2.  The Contribution of Matrix Metalloproteinase-8 Promoter Polymorphism to Oral Cancer Susceptibility.

Authors:  Yi-Wen Hung; Chia-Wen Tsai; Cheng-Nan Wu; Liang-Chun Shih; Yen-Yu Chen; Yen-Fang Liu; Huey-Shan Hung; Ming-Yi Shen; Wen-Shin Chang; DA-Tian Bau
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

Review 3.  Genotypic distribution of single nucleotide polymorphisms in oral cancer: global scene.

Authors:  Shaleen Multani; Dhananjaya Saranath
Journal:  Tumour Biol       Date:  2016-09-20

4.  Association between interferon gamma 13-CA-repeats polymorphism and metastasis of nasopharyngeal carcinoma in a population of Northern China.

Authors:  Kaifei Hao; Zhaohui Yan; Yu Shuang; Jinsong Sun; Shudong Tao; Wenyuan Fu; Lei Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Association between interleukin-10 gene polymorphisms and risk of oral carcinoma: A meta-analysis.

Authors:  Fan Li; Xing Xu; Chao Xuan; Wan-Tao Chen
Journal:  Histol Histopathol       Date:  2020-10-29       Impact factor: 2.303

6.  Association between IL-10 polymorphisms (-1082A/G, -592A/C and -819T/C) and oral cancer risk.

Authors:  Yuehua You; Xinya Du; Mingwen Fan; Bin Wu; Chun Xie
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  Circulating interleukin-10 levels and human papilloma virus and Epstein-Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects.

Authors:  Kai Qu; Qing Pang; Ting Lin; Li Zhang; Mingliang Gu; Wenquan Niu; Chang Liu; Ming Zhang
Journal:  Onco Targets Ther       Date:  2016-03-07       Impact factor: 4.147

8.  Interleukin-10 rs1800896 polymorphism is associated with increased head and neck cancer risk but not associated with its clinical stages.

Authors:  Wei Huang; Juan Song; Xiao-Wei Jia; Yin-Xue Chen; Jia Shi; Xun Jiang
Journal:  Oncotarget       Date:  2017-06-06

9.  Association of three promoter polymorphisms in interleukin-10 gene with cancer susceptibility in the Chinese population: a meta-analysis.

Authors:  Ping Wang; Junling An; Yanfeng Zhu; Xuedong Wan; Hongzhen Zhang; Shoumin Xi; Sanqiang Li
Journal:  Oncotarget       Date:  2017-05-26

10.  Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer: a meta-analysis.

Authors:  Yu-Ming Niu; Xin-Ya Du; Heng-Xing Cai; Chao Zhang; Rui-Xia Yuan; Xian-Tao Zeng; Jie Luo
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.